tumor-treating fields
-
September 6, 2022
Molecular Alterations Associated With Improved Outcome in Patients With Glioblastoma Treated With Tumor-Treating Fields Bookmark
George Lundberg, MDDo molecular biomarkers have any role in treating glioblastoma (GBM)? As outlined in this scientific research report from the academic journal Neuro-Oncology Research Advances, a recent study found that 3 biomarkers were correlated with very great outcome differences for people treated with tumor-treating (electrical) fields.
.
.
-
August 14, 2020
Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice Bookmark
George Lundberg, MDResearch paper from the Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
Safety and potential adverse effects are serious issues with many cancer treatments. This academic paper outlines post-marketing research that reveals few adverse effects from a type of treatment known as tumor-treating fields (TTF) in brain malignancies.
Go to full paper published in the Journal of Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas Bookmark
George Lundberg, MDResearch paper from Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
Tumor-treating fields (TTF) is a type of cancer treatment that uses alternating electric pulses. Its use for adults with high-grade gliomas remains controversial, and as outlined in this academic review paper, more high-quality research is needed.
Go to full paper published in Journal of Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.